| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Total adjusted ebitda | 477,822 | - |
| Interest expense (income), net | -114,714 | - |
| Income tax benefit (provision) | 15,889 | - |
| Depreciation, amortization and product development amortization | 180,676 | - |
| Restructuring and cost savings implementation charges | 4,880 | - |
| Advisory fees | 3,125 | - |
| Transaction and integration costs | 270 | - |
| Stock-based compensation | 31,076 | - |
| (gain) loss on extinguishment of debt | -16,361 | - |
| Other | 5,045 | - |
| Net income (loss) | 105,786 | 502 |
| Depreciation (including amortization of technology costs) | 34,910 | 17,187 |
| Amortization of intangibles | 113,750 | 57,365 |
| Amortization of product development costs | 32,016 | 13,302 |
| Amortization of capitalized contract costs-Royalty | 58,257 | 34,669 |
| Amortization of capitalized contract costs-Commission Costs | 12,633 | 7,435 |
| Stock-based compensation | 31,076 | - |
| Credit losses on accounts receivable | 236 | -2,286 |
| Unrealized (gain) loss on interest rate cap | 0 | 0 |
| Inventory obsolescence | 8,159 | 3,486 |
| Deferred income taxes | 942 | 864 |
| Amortization of debt discount | 6,841 | 3,352 |
| Amortization of deferred financing costs | 2,534 | 1,253 |
| (gain) loss on extinguishment of debt | -16,361 | - |
| Accounts receivable | 324,370 | 105,289 |
| Inventories | -33,526 | -10,544 |
| Prepaid and other current assets | 99,107 | 28,185 |
| Accounts payable and accrued expenses | -39,634 | -91,569 |
| Deferred revenue | 236,074 | -27,553 |
| Other current liabilities | -53,189 | 12,233 |
| Other changes in operating assets and liabilities, net | 8,470 | 3,962 |
| Cash provided by (used for) operating activities | 168,331 | -96,652 |
| Product development expenditures | 49,076 | 22,788 |
| Capital expenditures | 37,478 | 16,283 |
| Cash provided by (used for) investing activities | -86,554 | -39,071 |
| Payment of term loan facility | 392,283 | 3,292 |
| Borrowings on 2024 secured notes | 0 | - |
| Payment of finance lease obligations | 3,747 | 1,718 |
| Payment of deferred financing costs | 0 | - |
| Proceeds from issuance of common stock in initial public offering, net of underwriting discounts | 392,862 | - |
| Deferred initial public offering costs | 5,185 | 2,374 |
| Cash provided by (used for) financing activities | -8,353 | -7,384 |
| Effect of exchange rate changes on cash | -67 | 608 |
| Net change in cash and cash equivalents | 73,357 | -142,499 |
| Cash and cash equivalents at beginning of period | 389,830 | - |
| Cash and cash equivalents at end of period | 463,187 | - |
McGraw Hill, Inc. (MH)
McGraw Hill, Inc. (MH)